- Home
- Industry Reports
- Biotechnology
- Healthcare
- Global Genomics Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Genomics is a process and is completely computer-aided technology. It involves the study of genes at a molecular level, and in the determination of complete DNA sequences and perform genetic mapping to understand the disease. Global genomics market value was valued at $14.71 Billion in 2017 and is expected to generate revenue of around $29.03 Billion by the end of 2024, growing at a CAGR of around 10.2% between 2017 and 2024. Growing application areas of genomics and rising government funding and growth in the number of genomics projects are the factors enhancing the growth of the market. The high cost of equipment used in genomics and dearth of trained professionals are the factors which hamper the market growth. Use of genomics in specialised/ personalised medicine and emerging economies which offer significant growth are the opportunities for genomics market.
Research Study Objectives:
- Define, estimate, and forecast the Genomics market statistics by product and service, technology, process, application, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Genomics market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Genomics Market Analysis
- Analysis and conclusions on the future Genomics market outlook.
Top-down and bottom-up approaches are used to validate the Genomics Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Genomics Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Genomics market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Genomics market segmentation is as follows:
By Product and Service
- Instruments
- Consumables
- Services
By Technology
- Sequencing
- Microarray
- PCR
- Nucleic acid extraction and purification
- Other technologies
By Process
- Sequencing
- Library preparation
- Data analysis
By Application
- Diagnostics
- Drug discovery and development
- Precision medicine
- Agriculture & animal research
- Other applications
By End User
- Research centres
- Academic & government institutes
- Hospitals and clinics
- Pharmaceutical & biotechnology companies
- Other end users
Geographical Analysis:
Genomics market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Genomics Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Genomics Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Genomics market players, such as
- Thermo Fisher Scientific, Inc.
- Agilent Technologies Inc.
- Bio-Rad Laboratories.
- Illumina, Inc.
- Bayer Healthcare LLC.
- Along with these companies, many other companies are considered in the report while analysing the Global Genomics market competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing application areas of genomics
4.1.2. Reducing sequencing costs
4.1.3. Increasing government funding and growth in the number of genomics projects
4.1.4. Entry of new players and start-ups in the genomics market
4.2. Market Restraints & Challenges
4.2.1. Lack of trained professionals
4.2.2. Increasing the cost of equipment used in genomics
4.3. Market Opportunities
4.3.1. Use of genomics in specialised/ personalised medicine
4.3.2. Emerging economies
CHAPTER 5. GLOBAL GENOMICS MARKET – BY PROCESS
5.1. Introduction
5.2. Data analysis
5.3. Library preparation
5.4. Sequencing
CHAPTER 6. GLOBAL GENOMICS MARKET – BY TECHNOLOGY
6.1. Introduction
6.2. PCR
6.3. Microarray
6.4. Sequencing
6.5. Nucleic acid extraction and purification
6.6. Other technologies
CHAPTER 7. GLOBAL GENOMICS MARKET – BY PRODUCT AND SERVICE
7.1. Introduction
7.2. Consumables
7.3. Services
7.4. Instruments
CHAPTER 8. GLOBAL GENOMICS MARKET – BY APPLICATION
8.1. Introduction
8.2. Drug discovery and development
8.3. Agriculture &animal research
8.4. Precision medicine
8.5. Diagnostics
8.5.1. Cancer diagnostics
8.5.2. Monogenic (mendelian) disorders
8.5.3. Other diagnostic applications
8.5.3.1. Common diseases and complex disorders
8.5.3.2. Movement disorders
8.5.3.3. HIV
8.6. Other Applications
GLOBAL 9. GENOMICS MARKET – BY END USER
9.1. Introduction
9.2. Hospitals and clinics
9.3. Pharmaceutical & biotechnology companies
9.4. Research centres
9.5. Academic & government institutes
9.6. Other end users
CHAPTER 10. GLOBAL GENOMICS MARKET – BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11. GLOBAL GENOMICS MARKET – COMPANY PROFILES
11.1. Thermo Fisher Scientific, Inc.
11.2. Agilent Technologies Inc.
11.3. Qiagen N.V.
11.4. Bio-Rad Laboratories.
11.5. Illumina, Inc.
11.6. F. Hoffmann-La Roche Ltd.
11.7. Bayer Healthcare LLC.
11.8. PerkinElmer Inc.
11.9. Ge Healthcare.
11.10. Pacific Biosciences of California, Inc.
11.11. Myriad Genetics Inc.
11.12. Luminex Corporation.
11.13. Danaher Corporation.
11.14. EuroClone S.p.A.
11.15. Irvine Scientific Sales Company, Inc.
CHAPTER 12. GLOBAL GENOMICS MARKET – COMPETITIVE LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3.Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13. MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14. APPENDIX
14.1. List of Tables
14.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,561.91 - €7,685.74
- INR: ₹224,524.77 - ₹673,574.30
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,211.78 - £6,635.33
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Genomics is a process and is completely computer-aided technology. It involves the study of genes at a molecular level, and in the determination of complete DNA sequences and perform genetic mapping to understand the disease. Global genomics market value was valued at $14.71 Billion in 2017 and is expected to generate revenue of around $29.03 Billion by the end of 2024, growing at a CAGR of around 10.2% between 2017 and 2024. Growing application areas of genomics and rising government funding and growth in the number of genomics projects are the factors enhancing the growth of the market. The high cost of equipment used in genomics and dearth of trained professionals are the factors which hamper the market growth. Use of genomics in specialised/ personalised medicine and emerging economies which offer significant growth are the opportunities for genomics market.
Research Study Objectives:
- Define, estimate, and forecast the Genomics market statistics by product and service, technology, process, application, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Genomics market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Genomics Market Analysis
- Analysis and conclusions on the future Genomics market outlook.
Top-down and bottom-up approaches are used to validate the Genomics Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Genomics Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Genomics market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Genomics market segmentation is as follows:
By Product and Service
- Instruments
- Consumables
- Services
By Technology
- Sequencing
- Microarray
- PCR
- Nucleic acid extraction and purification
- Other technologies
By Process
- Sequencing
- Library preparation
- Data analysis
By Application
- Diagnostics
- Drug discovery and development
- Precision medicine
- Agriculture & animal research
- Other applications
By End User
- Research centres
- Academic & government institutes
- Hospitals and clinics
- Pharmaceutical & biotechnology companies
- Other end users
Geographical Analysis:
Genomics market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Genomics Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Genomics Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Genomics market players, such as
- Thermo Fisher Scientific, Inc.
- Agilent Technologies Inc.
- Bio-Rad Laboratories.
- Illumina, Inc.
- Bayer Healthcare LLC.
- Along with these companies, many other companies are considered in the report while analysing the Global Genomics market competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing application areas of genomics
4.1.2. Reducing sequencing costs
4.1.3. Increasing government funding and growth in the number of genomics projects
4.1.4. Entry of new players and start-ups in the genomics market
4.2. Market Restraints & Challenges
4.2.1. Lack of trained professionals
4.2.2. Increasing the cost of equipment used in genomics
4.3. Market Opportunities
4.3.1. Use of genomics in specialised/ personalised medicine
4.3.2. Emerging economies
CHAPTER 5. GLOBAL GENOMICS MARKET – BY PROCESS
5.1. Introduction
5.2. Data analysis
5.3. Library preparation
5.4. Sequencing
CHAPTER 6. GLOBAL GENOMICS MARKET – BY TECHNOLOGY
6.1. Introduction
6.2. PCR
6.3. Microarray
6.4. Sequencing
6.5. Nucleic acid extraction and purification
6.6. Other technologies
CHAPTER 7. GLOBAL GENOMICS MARKET – BY PRODUCT AND SERVICE
7.1. Introduction
7.2. Consumables
7.3. Services
7.4. Instruments
CHAPTER 8. GLOBAL GENOMICS MARKET – BY APPLICATION
8.1. Introduction
8.2. Drug discovery and development
8.3. Agriculture &animal research
8.4. Precision medicine
8.5. Diagnostics
8.5.1. Cancer diagnostics
8.5.2. Monogenic (mendelian) disorders
8.5.3. Other diagnostic applications
8.5.3.1. Common diseases and complex disorders
8.5.3.2. Movement disorders
8.5.3.3. HIV
8.6. Other Applications
GLOBAL 9. GENOMICS MARKET – BY END USER
9.1. Introduction
9.2. Hospitals and clinics
9.3. Pharmaceutical & biotechnology companies
9.4. Research centres
9.5. Academic & government institutes
9.6. Other end users
CHAPTER 10. GLOBAL GENOMICS MARKET – BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11. GLOBAL GENOMICS MARKET – COMPANY PROFILES
11.1. Thermo Fisher Scientific, Inc.
11.2. Agilent Technologies Inc.
11.3. Qiagen N.V.
11.4. Bio-Rad Laboratories.
11.5. Illumina, Inc.
11.6. F. Hoffmann-La Roche Ltd.
11.7. Bayer Healthcare LLC.
11.8. PerkinElmer Inc.
11.9. Ge Healthcare.
11.10. Pacific Biosciences of California, Inc.
11.11. Myriad Genetics Inc.
11.12. Luminex Corporation.
11.13. Danaher Corporation.
11.14. EuroClone S.p.A.
11.15. Irvine Scientific Sales Company, Inc.
CHAPTER 12. GLOBAL GENOMICS MARKET – COMPETITIVE LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3.Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13. MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14. APPENDIX
14.1. List of Tables
14.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.